Showing results (371-380 of 402) with videos related to

Sort By:
Pageof 41
European Journal of Heart Failure|October 2, 2020
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of CardiologyRadek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
European Journal of Heart Failure|February 19, 2021
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure AssociationBiykem Bozkurt, Andrew J S Coats, Hiroyuki Tsutsui, et al.
ESC Heart Failure|September 29, 2021
HFA of the ESC position paper on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider Part 3: at the hospital and dischargeFinn Gustafsson, Binyamin Ben Avraham, Ovidiu Chioncel, et al.
ESC Heart Failure|September 14, 2021
HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non-hospital settings in the communityBinyamin Ben Avraham, Marisa Generosa Crespo-Leiro, Gerasimos Filippatos, et al.
European Journal of Heart Failure|May 20, 2023
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of CardiologyMarco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Journal of Heart Failure|August 19, 2021
Guidance on the management of left ventricular assist device (LVAD) supported patients for the non-LVAD specialist healthcare provider: executive summaryTuvia Ben Gal, Binyamin Ben Avraham, Davor Milicic, et al.
European Journal of Heart Failure|May 4, 2025
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Ovidiu Chioncel, Alexandre Mebazaa, Dimitrios Farmakis, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 2024
Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOTMaria Simonenko, Dominique Hansen, Josef Niebauer, et al.
European Journal of Heart Failure|July 14, 2023
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESCMarco Metra, Marianna Adamo, Daniela Tomasoni, et al.
European Journal of Heart Failure|July 18, 2023
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of HypertensionStefan D Anker, Muhammad Shariq Usman, Markus S Anker, et al.
Pageof 41